A detailed history of Farmers National Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Farmers National Bank holds 5,726 shares of ABBV stock, worth $983,325. This represents 0.3% of its overall portfolio holdings.

Number of Shares
5,726
Holding current value
$983,325
% of portfolio
0.3%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 28, 2024

BUY
$154.79 - $180.76 $886,327 - $1.04 Million
5,726 New
5,726 $982 Million
Q1 2024

Aug 28, 2024

SELL
$159.82 - $182.1 $27,808 - $31,685
-174 Reduced 2.9%
5,820 $1.06 Billion
Q4 2023

Aug 28, 2024

BUY
$137.6 - $154.97 $36,876 - $41,531
268 Added 4.68%
5,994 $929 Million
Q3 2023

Aug 28, 2024

SELL
$133.59 - $154.65 $18,034 - $20,877
-135 Reduced 2.15%
6,136 $915 Million
Q2 2023

Aug 28, 2024

BUY
$132.51 - $164.9 $72,217 - $89,870
545 Added 9.52%
6,271 $845 Million
Q1 2023

Aug 28, 2024

SELL
$144.61 - $166.54 $23,282 - $26,812
-161 Reduced 2.32%
6,770 $1.08 Billion
Q4 2022

Aug 28, 2024

SELL
$138.31 - $165.87 $18,118 - $21,728
-131 Reduced 1.85%
6,931 $1.12 Billion
Q3 2022

Aug 28, 2024

SELL
$134.21 - $153.93 $46,436 - $53,259
-346 Reduced 4.67%
7,062 $948 Million
Q2 2022

Aug 28, 2024

BUY
$137.62 - $174.96 $231,476 - $294,282
1,682 Added 29.37%
7,408 $1.13 Billion
Q1 2022

Aug 28, 2024

SELL
$131.98 - $163.75 $2,375 - $2,947
-18 Reduced 0.23%
7,890 $1.28 Billion
Q4 2021

Aug 28, 2024

BUY
$107.43 - $135.93 $147,286 - $186,360
1,371 Added 20.97%
7,908 $1.07 Billion
Q3 2021

Aug 28, 2024

BUY
$106.4 - $120.78 $695,536 - $789,538
6,537 New
6,537 $705,000
Q2 2021

Aug 28, 2024

SELL
$105.21 - $117.21 $638,414 - $711,230
-6,068 Closed
0 $0
Q1 2021

Aug 28, 2024

BUY
$102.3 - $112.62 $34,986 - $38,516
342 Added 5.97%
6,068 $657 Million
Q4 2020

Aug 28, 2024

BUY
$80.49 - $108.67 $65,277 - $88,131
811 Added 14.16%
6,537 $700 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Farmers National Bank Portfolio

Follow Farmers National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farmers National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Farmers National Bank with notifications on news.